Scientists discover most Acinetobacter baumannii  infections at Malaysian hospital belonged to specific type of bacteria.

BioVersys highlighted the urgent need for safe treatments for CRAB infections, which can have death rates in hospitals as ...

Pathogen causes severe disease and poses significant challenges to global public health, with an urgent need for continuous ...

The virulent strain of antibiotic-resistant microbes causes severe disease, posing significant challenges to global public ...

The antibiotic-resistant ‘superbug' causes severe disease and poses significant challenges to global public health ...

Even better, they discovered that lariocidin—named for its knotted, lasso-like chemical structure—has a unique mechanism of ...

Ad hoc announcement pursuant to Art. 53 LR Important patent around BioVersys’ BV100 drug candidate has been granted, protecting the proprietary rifabutin IV formulation technology in China BV100 ...

According to the study, Thymol may help weaken bacteria, thereby offering a potential approach for tackling persistent ...

March 26, 2025, 7am CET BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious ...

In this study, authors conduct a genomic analysis of 15,000 Acinetobacter baumannii isolates, revealing a dominant multidrug-resistant super-lineage (accounting for approximately 70% global ...